IBDEI0NE ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11512,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11512,1,1,0)
 ;;=1^710.1
 ;;^UTILITY(U,$J,358.3,11512,1,2,0)
 ;;=2^SYSTEMIC SCLEROSIS
 ;;^UTILITY(U,$J,358.3,11512,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,11513,0)
 ;;=446.7^^76^755^20
 ;;^UTILITY(U,$J,358.3,11513,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11513,1,1,0)
 ;;=1^446.7
 ;;^UTILITY(U,$J,358.3,11513,1,2,0)
 ;;=2^TAKAYASU'S DISEASE
 ;;^UTILITY(U,$J,358.3,11513,2)
 ;;=^117141
 ;;^UTILITY(U,$J,358.3,11514,0)
 ;;=446.6^^76^755^21
 ;;^UTILITY(U,$J,358.3,11514,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11514,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,11514,1,2,0)
 ;;=2^THROMBOT MICROANGIOPATHY
 ;;^UTILITY(U,$J,358.3,11514,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,11515,0)
 ;;=446.4^^76^755^22
 ;;^UTILITY(U,$J,358.3,11515,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11515,1,1,0)
 ;;=1^446.4
 ;;^UTILITY(U,$J,358.3,11515,1,2,0)
 ;;=2^WEGENER'S GRANULOMATOSIS
 ;;^UTILITY(U,$J,358.3,11515,2)
 ;;=^127623
 ;;^UTILITY(U,$J,358.3,11516,0)
 ;;=444.9^^76^755^9
 ;;^UTILITY(U,$J,358.3,11516,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11516,1,1,0)
 ;;=1^444.9
 ;;^UTILITY(U,$J,358.3,11516,1,2,0)
 ;;=2^OTH ARTERIAL EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,11516,2)
 ;;=^39452
 ;;^UTILITY(U,$J,358.3,11517,0)
 ;;=710.9^^76^755^10
 ;;^UTILITY(U,$J,358.3,11517,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11517,1,1,0)
 ;;=1^710.9
 ;;^UTILITY(U,$J,358.3,11517,1,2,0)
 ;;=2^OTH CONNECTIVE TISSUE DISEASE
 ;;^UTILITY(U,$J,358.3,11517,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,11518,0)
 ;;=453.9^^76^755^11
 ;;^UTILITY(U,$J,358.3,11518,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11518,1,1,0)
 ;;=1^453.9
 ;;^UTILITY(U,$J,358.3,11518,1,2,0)
 ;;=2^OTH VENOUS EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,11518,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,11519,0)
 ;;=441.00^^76^755^1
 ;;^UTILITY(U,$J,358.3,11519,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11519,1,1,0)
 ;;=1^441.00
 ;;^UTILITY(U,$J,358.3,11519,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/ DISSECTION
 ;;^UTILITY(U,$J,358.3,11519,2)
 ;;=^35660
 ;;^UTILITY(U,$J,358.3,11520,0)
 ;;=042.^^76^756^1
 ;;^UTILITY(U,$J,358.3,11520,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11520,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,11520,1,2,0)
 ;;=2^AIDS OR HIV INFECTION
 ;;^UTILITY(U,$J,358.3,11520,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,11521,0)
 ;;=540.9^^76^756^2
 ;;^UTILITY(U,$J,358.3,11521,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11521,1,1,0)
 ;;=1^540.9
 ;;^UTILITY(U,$J,358.3,11521,1,2,0)
 ;;=2^APPENDICITIS
 ;;^UTILITY(U,$J,358.3,11521,2)
 ;;=^270195
 ;;^UTILITY(U,$J,358.3,11522,0)
 ;;=682.9^^76^756^3
 ;;^UTILITY(U,$J,358.3,11522,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11522,1,1,0)
 ;;=1^682.9
 ;;^UTILITY(U,$J,358.3,11522,1,2,0)
 ;;=2^CELLULITIS AND ABSCESS
 ;;^UTILITY(U,$J,358.3,11522,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,11523,0)
 ;;=576.1^^76^756^4
 ;;^UTILITY(U,$J,358.3,11523,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11523,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,11523,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,11523,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,11524,0)
 ;;=574.70^^76^756^5
 ;;^UTILITY(U,$J,358.3,11524,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11524,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,11524,1,2,0)
 ;;=2^CHOLECYSTITIS
 ;;^UTILITY(U,$J,358.3,11524,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,11525,0)
 ;;=571.5^^76^756^6
 ;;^UTILITY(U,$J,358.3,11525,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11525,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,11525,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,11525,2)
 ;;=^24731
